XML 22 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities      
Net income (loss) $ 38,059 $ 29,111 $ (9,630)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities      
Depreciation and amortization 9,724 6,066 5,342
Net loss on disposal of equipment 84 234  
Stock-based compensation 2,297 2,252 937
Stock issued to board of directors 162    
Realized gain on investments   (8) (47)
Deferred taxes 13,447    
Excess tax benefits from stock-based compensation (1,404)    
Changes in operating assets and liabilities:      
Accounts receivable (13,968) (13,709) (2,425)
Inventories (11,948) (4,464) 1,285
Other inventory supplies (9,929) (5,646) 1,436
Prepaid expenses and other assets (3,993) (548) 38
Accounts payable 3,683 7,129 (445)
Accrued payroll (951) 2,020 (162)
Corporate income and franchise taxes 212 236 (84)
Advance payments (1,094) 1,076  
Accrued and other current liabilities 231 310 463
Net cash provided by (used in) operating activities 24,612 24,059 (3,292)
Cash flows from investing activities      
Purchases of property and equipment (48,228) (49,429) (5,530)
Proceeds from disposal of assets   143  
Purchase of investments (9,439) (55,416) (693)
Proceeds from sale of investments 25,000 30,000 7,922
Net cash (used in) provided by investing activities (32,667) (74,702) 1,699
Cash flows from financing activities      
Proceeds from issuance of common stock, net of issuance costs of $4,130   61,720  
Proceeds from exercise of options 742 1,640 420
Restricted cash 344 (525) (3)
Purchase of treasury stock (6,487)   (2,577)
Excess tax benefits from stock-based compensation 1,404    
Net cash (used in) provided by financing activities (3,997) 62,835 (2,160)
Net effect of currency translation 269 21 (16)
Net (decrease) increase in cash and cash equivalents (11,783) 12,213 (3,769)
Cash and cash equivalents, beginning of year 16,073 3,860 7,629
Cash and cash equivalents, end of year 4,290 16,073 3,860
Supplemental disclosure of cash flow information      
Cash paid for income taxes 6,050    
Supplemental disclosure of non cash items of cash flow information      
Unrealized loss on investments (42) (9) (126)
Deferred offering costs included in accounts payable     61
Stock-based compensation incurred for accrued director's fees     $ 36